Abionyx Pharma SA (ABNX) — Strategic Asset Allocation Index

Abionyx Pharma SA (ABNX) has a Strategic Asset Allocation Index of 35.6% as of June 2025. Strategic assets (PP&E of €1.93 Million plus long-term investments of €-) total €1.93 Million, measured against net assets of €5.41 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Abionyx Pharma SA net asset quality index to measure how much of total assets are equity-financed.